Cardiorenal Disease is the Costliest CVD in Type 2 Diabetes: A Large Long-Term Observational Study

被引:1
|
作者
Eriksson, Jan W. [1 ]
Bodegard, Johan [2 ]
Thuresson, Marcus [3 ]
BillyMamza, Jil [4 ]
Norhammar, Anna [5 ,6 ]
机构
[1] Uppsala Univ, Dept Med Sci Clin Diabet & Metab, Uppsala, Sweden
[2] AstraZeneca, Oslo, Norway
[3] Statisticon AB, Uppsala, Sweden
[4] AstraZeneca, Luton, Beds, England
[5] Karolinska Inst, Dept Med, Cardiol Unit, Stockholm, Sweden
[6] Capio St Gorans Hosp, Stockholm, Sweden
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 2020年 / 104卷
关键词
heart failure; chronic kidney disease; health care cost; observational study; type; 2; diabetes;
D O I
10.1016/j.metabol.2019.12.080
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Long-term cardiorenal efficacy of finerenone in patients with chronic kidney disease and type 2 diabetes
    Qiu, Mei
    Zhao, Li-Min
    ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (10) : 11239 - 11241
  • [2] Medication Prescribing for Type 2 Diabetes in the US Long-Term Care Setting: Observational Study
    Pandya, Naushira
    Jung, Molly
    Norfolk, Aaron
    Goldblatt, Claudia
    Trenery, Alyssa
    Sieradzan, Ray
    JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2023, 24 (06) : 790 - 797.e4
  • [3] Cardiorenal disease is the most frequent cardiovascular manifestation in type 2 diabetes and associated with increased cardiovascular death: a large observational study in England
    Zhang, Ruiqi
    Mamza, Jil Billy
    Morris, Tamsin
    Hastings, Rob
    Godfrey, George
    Bodegard, Johan
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2020, 104
  • [4] Cardiorenal disease is the most common first CV manifestation in type 2 diabetes and associated with increased mortality: a large multinational observational study
    Birkeland, K.
    Bodegard, J.
    Eriksson, J.
    Norhammar, A.
    Thuresson, M.
    Pignot, M.
    Garal-Pantaler, E.
    Yajima, T.
    Komuro, I.
    Kadowaki, T.
    DIABETOLOGIA, 2019, 62 : S66 - S66
  • [5] Cardiorenal Disease Is the Most Common First CV Manifestation in Type 2 Diabetes and Associated with Increased Mortality: A Large Multinational Observational Study
    Birkeland, Kare I.
    Bodegard, Johan
    Thuresson, Marcus
    Eriksson, Jan W.
    Norhammar, Anna
    Yajima, Toshitaka
    Komuro, Issei
    Kadowaki, Takashi
    DIABETES, 2019, 68
  • [6] Long-term progression of retinopathy after initiation of insulin therapy in Type 2 diabetes: an observational study
    C. S. Arun
    R. Pandit
    R. Taylor
    Diabetologia, 2004, 47 : 1380 - 1384
  • [7] Ethnicity and long-term vascular outcomes in Type 2 diabetes: a prospective observational study (UKPDS 83)
    Davis, T. M. E.
    Coleman, R. L.
    Holman, R. R.
    DIABETIC MEDICINE, 2014, 31 (02) : 200 - 207
  • [8] Long-term progression of retinopathy after initiation of insulin therapy in Type 2 diabetes: an observational study
    Arun, CS
    Pandit, R
    Taylor, R
    DIABETOLOGIA, 2004, 47 (08) : 1380 - 1384
  • [9] Long-term effectiveness of insulin pump in type 2 diabetes: an observational study conducted in 111 patients.
    Reznik, Y.
    Morera, J.
    Rod, A.
    Coffin, C.
    Rousseau, E.
    Lireux, B.
    Joubert, M.
    DIABETES & METABOLISM, 2010, 36 : A21 - A21
  • [10] Long-Term Mortality and SGLT2 Inhibitors in Type 2 Diabetes with and without Renal Impairment: An Observational Cohort Study
    Al-Muhaiteeb, Abdullah
    Alahmad, Barrak
    Abu-Farha, Mohamed
    Abubaker, Jehad
    Thanaraj, Thangavel A.
    Ali, Hamad
    Al-Mulla, Fahd
    Qaddoumi, Mohammad
    MEDICAL PRINCIPLES AND PRACTICE, 2024, 33 (03) : 251 - 259